TSTatyana V. Sokolovskaya

Tatyana V. Sokolovskaya

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Tatyana V. Sokolovskaya has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Analysis of quantitative optical coherence tomography angiography parameters after one-stage combined treatment of primary open-angle glaucoma and complicated cataract

    by Natalia A. Morina, Морина Наталья Александровна, Краснова Екатерина Олеговна, Ekaterina O. Krasnova, Tatyana V. Sokolovskaya, Соколовская Татьяна Викторовна, Grigory V. Sorokoletov, Сороколетов Григорий Владимирович

    BACKGROUND: Despite the widespread adoption of micropulse laser cyclophotocoagulation in clinical practice, data on its use as part of one-stage combined treatment for primary open-angle glaucoma and complicated cataract remain limited. In particular, changes in the quantitative parameters of the macular region, as assessed by optical coherence tomography angiography, after combining phacoemulsification of cataract and micropulse cyclophotocoagulation have not been sufficiently studied. AIM: To analyze the changes in the quantitative parameters of the vascular system of the macular region based on optical coherence tomography angiography data after one-stage combined laser surgical treatment of primary open-angle glaucoma and complicated cataract. METHODS: The study included patients with complicated cataracts in combination with primary open-angle glaucoma at the initial and advanced stages, who had not previously undergone surgery for glaucoma or other ophthalmic pathologies. All patients underwent one-stage combined treatment, which included phacoemulsification of the cataract with implantation of an intraocular lens and micropulse cyclophotocoagulation. In addition to the standard ophthalmological examination, optical coherence tomography angiography of the macular region was performed according to the Angiography 6 × 6 mm protocol, with assessment of perfusion density, vessel density, and parameters of the foveal avascular zone. The study was carried out before surgery, and 1 and 6 months after the intervention. RESULTS: Initially, 31 patients (36 eyes) were included in the study; after excluding 2 patients, the final analysis was performed on 29 patients (34 eyes). After the surgery, a statistically significant increase in best-corrected visual acuity was observed (an increase of 0.51 at 6 months [95% CI 0.44–0.59], p 0.001), as well as a statistically significant reduction in intraocular pressure (by 3.18 mm Hg at 1 month [95% CI 1.56–4.79], p 0.001), followed by stabilization of the value at 6 months. According to optical coherence tomography angiography, statistically significant changes in perfusion density and vessel density were detected: 1 month after surgery, an increase in these parameters compared to preoperative values was observed; subsequently, a tendency toward their reduction was noted, with a return to the initial parameters. No statistically significant changes were found for the quantitative indicators of the foveal avascular zone. CONCLUSION: One-stage combined treatment of primary open-angle glaucoma and complicated cataract is not accompanied by clinically significant adverse changes in macular hemodynamics according to optical coherence tomography angiography. The detected changes in perfusion density and vascular density parameters are moderate and transient, reaching maximum severity in the early postoperative period and demonstrating a tendency toward stabilization in the long-term postoperative period.

  • Corneal endothelium status as a criterion for assessing the safety of the technique in the combined treatment of patients with glaucoma and cataract

    by E. O. Krasnova, G. V. Sorokoletov, T. V. Sokolovskaya

    PURPOSE. To evaluate corneal endothelial status in patients with primary open-angle glaucoma and complicated cataract undergoing combined micropulse transscleral cyclophotocoagulation (MP-CPC) and cataract phacoemulsification with intraocular lens implantation (PE+IOL). METHODS. This prospective study included 62 patients with stage I–II primary open-angle glaucoma and complicated cataract who underwent surgical treatment. The study group comprised 33 patients who received combined intervention (MP-CPC+PE+IOL), while the control group included 32 patients who only underwent PE+IOL. Corneal endothelial status was assessed using the Tomey EM-3000 specular microscope preoperatively and at 1, 3, 6, and 12 months after surgery. RESULTS. In both groups, a moderate decrease in endothelial cell density was observed during the early postoperative period, with the most pronounced reduction at 1 month (up to 11.8%), followed by stabilization. At 12 months, the mean endothelial cell loss was less than 10%, with no statistically significant differences between the groups (p>0.05). Best-corrected visual acuity improved significantly compared with baseline. No progression of glaucomatous damage was detected by perimetry and optical coherence tomography. The incidence of postoperative intraocular pressure elevation was comparable between the groups. CONCLUSION. The combined use of MP-CPC and PE+IOL demonstrates a satisfactory safety profile and does not exert a significant negative effect on corneal endothelial status compared with isolated phacoemulsification. The obtained results support the feasibility of the combined approach in patients with concomitant ophthalmic pathology.

  • Open Access

    Micropulse laser cyclophotocoagulation in the treatment of secondary glaucoma in patients with post-burn and terminal dystrophic corneal leukoma as a stage of preparation for keratoprosthesis surgery

    by T. V. Sokolovskaya, A. V. Golovin, A. V. Starostina, V. R. Sholokhova, L. A. Shishkova

    PURPOSE. To evaluate the effectiveness of micropulse laser cyclophotocoagulation (mCPC) in patients with secondary glaucoma associated with post-burn and terminal dystrophic corneal leukomas.METHODS. Twelve patients (12 eyes) with corneal leukomas and secondary glaucoma underwent mCPC. The mean age of the patients was 44±6.5 years, including 8 men and 4 women. All patients exhibited elevated intraocular pressure (IOP), ranging from Tpalp "+" to Tpalp "++," despite being on maximum combination hypotensive therapy. Visual acuity for all patients was 1/∞ light perception with correct projection (proectia lucis certa).RESULTS. On the first postoperative day, IOP was reduced to Tpalp "+" in 4 patients and to Tpalp "N" in 8 patients. Hypotensive therapy was continued based on individual indications throughout the observation period. By day 7, IOP had decreased to Tpalp "N" in all patients and remained stable throughout the follow-up period. Visual acuity in all cases remained unchanged from the preoperative level. Ultrasound biomicroscopy (UBM) revealed that the mean ciliary body thickness (CBT) before surgery was 0.56±0.11 mm. On the first postoperative day, CBT increased by an average of 20.1% due to pronounced edema caused by hydration from the inflammatory response, with a gradual return to baseline by the 1-month follow-up. At 6 months, no statistically significant difference in CBT from the preoperative thickness was observed, with a mean CBT of 0.50±0.12 mm.CONCLUSIONS. Micropulse cyclophotocoagulation can be an effective treatment for secondary glaucoma in patients with post-burn and terminal dystrophic corneal leukomas. This technique reduces the risk of intraoperative and postoperative complications due to its non-invasive nature and low surgical trauma. The procedure can be repeated if IOP increases, and gentle laser parameters can help preserve visual potential.


  • Open Access

    The effectiveness of combined laser treatment technology in patients with glaucoma

    by T. V. Sokolovskaya, G. Yu. Usanova, E. O. Krasnova

    Purpose: to study the effectiveness of combined laser treatment in patients with the advanced primary open-angle glaucoma (POAG).Material and methods: the present study included 63 patients with POAG. They were divided into the studied group (32 eyes) and control group (31 eye). Patients age ranged from 65 to 78 years (mean 70.68 ± 4.39 years in the studied group and 69.48 ± 3.82 in the control group). Intraocular pressure (IOP) in all patients was compensated with antihypertensive drops, and in average was 20.36 ± 1.27 mm Hg in the studied group and 20.02 ± 1.43 mm Hg in the control group. The number of antihypertensive drugs used before surgery ranged from 2 to 3 (average 2.40 ± 0.49 in the studied group and 2.51 ± 0.50 in the control group). YAG-LAT was performed with Lightlas YAG Nd-YAG laser (Lightmed, USA). Microimpulse transcleral cyclophotocoagulation (mTS-CPC) was performed with Cyclo G6 Glaucoma Laser System (IRIDEX, USA). In the studied group, all patients had YAG-LAT with mTS-CPC; in the control group – mTS-CPC. Patients were examined on days 1 and 7; and then in 1, 3 and 6 months after the treatment. The obtained results were summarized in a table and were statistically processed.Results: in the studied group, on day 1 after the intervention IOP was (mm Hg): 19.36 ± 1.36, in the control group – 19.45 ± 1.15; on day 7: studied group – 20.59 ± 1.5, control group – 19.9 ± 2.68; in one month: studied group – 13.95 ± 1.67, control group – 15.8 ± 1.5; in three months: studied group – 15.04 ± 1.13, control group – 16.48 ± 1.12; in 6 months: studied group – 15.27 ± 1.77, control group – 16.23 ± 1.41.Conclusion: the combined laser technology which includes YAG-laser activation of the trabecula and mTS-CPC is an effective and safe method for lowering intraocular pressure in patients with glaucoma

  • Open Access

    Acute glaucoma attack in a patient recovered from coronavirus infection (case report)

    by T. V. Sokolovskaya, V. N. Gutnik, Е. О. Krasnova

    The prevalence of ophthalmic manifestations in COVID-19 ranges from 2 to 32%. The most common ophthalmic disease associated with COVID-19 is viral conjunctivitis, but there are also reports of cases with episcleritis, uveitis, occlusions of the central retinal artery and vein, retinopathy, glaucoma, dry eye syndrome, as well as rare neuroophthalmological manifestations such as diplopia, ophthalmoplegia and nystagmus. This study reports a case of bilateral acute angle-closure glaucoma attack in a patient recovered from severe COVID-19 pneumonia.PURPOSE. To determine the causes of bilateral acute angle-closure glaucoma attack associated with COVID-19 pneumonia, and to evaluate the effectiveness of laser iridotomy and transciliary drainage of the posterior chamber of the eye.METHODS. Bilateral acute angle closure glaucoma attack was observed in a female patient recovered from COVID-19 pneumonia. Low hypermetropia and co-existing cataract were diagnosed in both eyes. In order to normalize the IOP and restore visual acuity, laser iridotomy was performed in both eyes, followed by surgical treatment of glaucoma with transciliary drainage of the posterior chamber in both eyes. After that the patient underwent phacoemulsification with implantation of intraocular lenses (IOL) in both eyes.RESULTS. Laser iridotomy and transciliary drainage of the posterior chamber was performed in both eyes. The target IOP without topical therapy and stabilization of glaucoma were achieved in both eyes. The second step was phacoemulsification with implantation of IOL, which significantly improved visual acuity of both eyes.CONCLUSION. COVID-19 can lead to vision loss and disability, therefore IOP should be monitored in patients that remain in prone position for ventilation for extended periods of time and receive systemic steroid medications. This is especially relevant for patients with a predisposition to glaucoma or with diagnosed glaucoma.